Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 11 Jun 2026 for HARVARD BIOSCIENCE INC. Read the official filing
Filing timeline
BuySaleStephen J. Denelsky
Insider track record
Disclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Stephen J. Denelsky: trading record in brief
Stephen J. Denelsky appears in our data through filings on Harvard Bioscience Inc shares, published by SEC (Form 4). In total, 3 filings cover trades dated from 5 September 2025 to 9 June 2026.
Purchases make up the whole of the open-market record (1 purchase, €42k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 2 share grants. So far in 2026, the count stands at 1 purchase and no sales.
On 11 June 2026 came the latest disclosure, a share grant in Harvard Bioscience Inc. The last purchase on record was published on 18 March 2026, which is 214 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Stephen J. Denelsky
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
16,556 sharesCommon StockSEC:0001171843-26-004058:0
10,000 shares@ US$4.87100.0% of flowCommon StockSEC:0001171843-26-001732:0
Canonical exit: 15 Jun 2026 (T+90)
110,000 shares0Common StockSEC:0001171843-25-006325:0
3 of 3 declarations
